AstraZeneca PLC

Change company Symbol lookup

Select an option...

AZN AstraZeneca PLC

TD Toronto-Dominion Bank

OTGLF CD Projekt SA

HRL Hormel Foods Corp

IPOF Social Capital Hedosophia Holdings Corp VI

NIO NIO Inc

NRT North European Oil Royalty Trust

JNJ Johnson & Johnson

STAG STAG Industrial Inc

TM Toyota Motor Corp

Go

Positive high-level results from the ELEVATE-RR Phase III trial showed AstraZeneca's CALQUENCE(R) (acalabrutinib) met the primary endpoint demonstrating non-inferior progression-free survival (PFS) for adults with previously treated, high-risk...(BusinessWire)

China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that...(PR Newswire)

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s ENHERTU(R) (fam-trastuzumab deruxtecan-nxki) has been approved in the US for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or...(BusinessWire)

Facts and Factors have published a new research report titled "mHealth Apps Market By Type (Fitness, Lifestyle Management, Nutrition & Diet, Women's Health, Medication Adherence, Healthcare Providers/ Payors, Disease Management, and...(Globe Newswire)

--New non-small cell lung cancer data for TAGRISSO(R) and IMFINZI(R) further demonstrate the impact of treating patients in early stages of the disease AstraZeneca will present new data from across the innovative lung cancer portfolio at the IASLC...(BusinessWire)

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary...(Globe Newswire)

AstraZeneca's FARXIGA (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type 2 diabetes (T2D). The Food and Drug Administration (FDA) grants...(BusinessWire)

AstraZeneca's TAGRISSO(R) (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative...(BusinessWire)

Mentor Capital, Inc. (OTCQB: MNTR) announced that it has added a business segment that focuses on the vaccine and associated medical companies involved in the fight against SARS-CoV-2. The initial public companies in the small internal portfolio are...(BusinessWire)

Reportlinker.com announces the release of the report "Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and Change" - https://www.reportlinker.com/p05999220/?utm_source=GNW (Globe Newswire)

AstraZeneca's TAGRISSO(R) (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative...(BusinessWire)

https://mma.prnewswire.com/media/443626/Monteverde_Associates_PC_Logo.jpg Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is...(PR Newswire)

Reportlinker.com announces the release of the report "Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change" - https://www.reportlinker.com/p05998718/?utm_source=GNW (Globe Newswire)

Soft tissue sarcoma (STS) is a rare type of cancer that develops in tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Generally occurring in the muscles, tissues, and blood vessels that protect, support and surround the...(PR Newswire)

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary...(Globe Newswire)

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share is...(BusinessWire)

Reportlinker.com announces the release of the report "Arthritis Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change" - https://www.reportlinker.com/p05995334/?utm_source=GNW (Globe Newswire)

Reportlinker.com announces the release of the report "Immuno-Oncology Drugs Global Market Report 2020-30: COVID-19 Growth and Change" - https://www.reportlinker.com/p05995343/?utm_source=GNW The global immuno-oncology drugs market is expected to...(Globe Newswire)

--Update shows encouraging landmark survival in exploratory analysis with an estimated three out of four patients alive at 18 months Updated results from the positive DESTINY-Breast01 Phase II trial showed AstraZeneca and Daiichi Sankyo Company...(BusinessWire)

All around the globe, scientists are working hard to develop effective treatments, therapies and vaccines to halt the COVID-19 pandemic. Therapies that are under investigation include drugs that have been used to treat malaria and autoimmune...(PR Newswire)